Psychedelics Today is the planetary leader in psychedelic media, storytelling, events, and education. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.
In this episode of the podcast, Joe interviews Greg McKee: Chairman and CEO of Tryp Therapeutics, an early-stage biotech company researching the use of psilocybin derivatives to alleviate nociplastic pain like fibromyalgia.